Although some serum markers did not reach statistical significance, likely due to the limited sample size, the consistent trends across patient groups reinforce the biological relevance of complement dysregulation in MPN-related thrombosis.
← all excerpts
Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasms.
1
—
—